Article Details
Retrieved on: 2021-02-17 21:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... myeloma, especially those who have previously received the first-generation PI bortezomib (Velcade), monoclonal antibodies, and lenalidomide.
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here